1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen
(
- Contribution to journal › Article
-
Mark
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
(
- Contribution to journal › Article
-
Mark
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Prediction of tumor heterogeneity in localized prostate cancer
(
- Contribution to journal › Article
- 2000
-
Mark
Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer
(
- Contribution to journal › Article
- 1999
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
(
- Contribution to journal › Article